The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune profiling in patients with glioblastoma treated with VT1021 in a phase I/II expansion study.
 
Jian Jennifer Chen
Employment - Vigeo Therapeutics
Stock and Other Ownership Interests - Vigeo Therapeutics
 
Melanie Vincent
Employment - Vigeo Therapeutics
Stock and Other Ownership Interests - Vigeo Therapeutics
 
David M. Peereboom
Consulting or Advisory Role - Novocure; Orbus Therapeutics; Stemline Therapeutics; Sumitomo Dainippon Pharma Oncology, Inc.
Research Funding - Apollomics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Global Coalition for Adaptive Research (Inst); Karyopharm Therapeutics (Inst); MimiVax (Inst); Mylan (Inst); Neonc Technologies (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); Vigeo Therapeutics (Inst)
Other Relationship - IN8bio (Inst)
 
Randolph Watnick
Employment - Vigeo Therapeutics (I)
Leadership - Vigeo Therapeutics (I)
Stock and Other Ownership Interests - Vigeo Therapeutics
Consulting or Advisory Role - Vigeo Therapeutics
Patents, Royalties, Other Intellectual Property - I am the inventor of patents licensed by Vigeo Therapeutics, Inc relating the the composition of matter of therapeutic peptides derived from prosaposin.
 
Susanne Fyfe
Employment - Twentyeight-Seven Therapeutics (I); Vigeo Therapeutics
Stock and Other Ownership Interests - Twentyeight-Seven Therapeutics (I); Vigeo Therapeutics
 
Wendy Li
Employment - Finch Therapeutics; TScan Therapeutics (I); Verve Therapeutics (I); Vigeo Therapeutics
Stock and Other Ownership Interests - Finch Therapeutics; TScan Therapeutics (I); Verve Therapeutics (I); Vigeo Therapeutics
 
Suming Wang
Employment - Alkermes (I); Merck (I); Vigeo Therapeutics
Stock and Other Ownership Interests - Merck (I); Vigeo Therapeutics
 
James Mahoney
Employment - Vigeo Therapeutics
Leadership - Vigeo Therapeutics
Stock and Other Ownership Interests - Vigeo Therapeutics
Consulting or Advisory Role - Vigeo Therapeutics
Patents, Royalties, Other Intellectual Property - Vigeo Therapeutics
Travel, Accommodations, Expenses - Vigeo Therapeutics
 
Michael Cieslewicz
Employment - Vigeo Therapeutics
Stock and Other Ownership Interests - Novartis
 
Jing Watnick
Employment - Vigeo Therapeutics
Leadership - Vigeo Therapeutics
Stock and Other Ownership Interests - Vigeo Therapeutics